ask="N/A"
ask_size="N/A"
average_daily_volume="294532"
bid="N/A"
bid_size="N/A"
book_value="0.30"
change="-0.02"
change_from_200_day_moving_average="-0.30"
change_from_50_day_moving_average="0.04"
change_from_52_week_high="-1.34"
change_From_52_week_low="0.16"
change_in_percent="-2.39%"
close="1.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.54"
ebitda="-24.87M"
eps_estimate_current_year="-0.48"
eps_estimate_next_quarter="-0.15"
eps_estimate_next_year="-0.35"
ex_dividend_date="N/A"
float_shares="50898000"
high="1.06"
high_52_weeks="2.36"
last_trade_date="1/26/2017"
last_trade_price="1.02"
last_trade_size="128"
last_trade_time="4:02pm"
low="1.02"
low_52_weeks="0.86"
market_capitalization="56.86M"
moving_average_200_day="1.32"
moving_average_50_day="0.98"
name="Actinium Pharmaceuticals
Inc. "
notes="N/A"
one_year_target_price="7.33"
open="1.04"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-22.59%"
percent_change_from_50_day_moving_average="+3.77%"
percent_change_from_52_week_high="-56.78%"
percent_change_from_52_week_low="+18.60%"
previous_close="1.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.51"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="55747000"
short_ratio="4.32"
stock_exchange="ASE"
symbol="ATNM"
volume="125238"
weeks_range_52="0.86 - 2.36"
